Literature DB >> 23414932

REST: an oncogene or a tumor suppressor?

Sara Negrini1, Ilaria Prada, Rosalba D'Alessandro, Jacopo Meldolesi.   

Abstract

The Repressor Element-1 (RE-1) Silencing Transcription (REST) factor, which is highly expressed in stem cells and non-neural cells, with low expression in neurons and other neural cells, orchestrates neural differentiation and preserves the unique neural phenotype. REST also plays a role in proliferation, although its effect differs depending on the cell type. It acts as an oncogene in neural cells and tumors (medulloblastomas, neuroblastomas, glioblastomas) and as a tumor suppressor in carcinomas of the lung, breast, and colon. The mechanisms underlying this duality have started to emerge recently and new therapeutic approaches based on these findings are being developed. Here, we present the mechanisms proposed to account for the oncogenic and antioncogenic roles of REST and discuss the therapeutic perspective of recent advances, particularly for small-cell lung cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414932     DOI: 10.1016/j.tcb.2013.01.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  39 in total

1.  REST represses miR-124 and miR-203 to regulate distinct oncogenic properties of glioblastoma stem cells.

Authors:  Anantha L Marisetty; Sanjay K Singh; Tran N Nguyen; Cristian Coarfa; Bin Liu; Sadhan Majumder
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

2.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

3.  RE1-silencing Transcription Factor (REST) Is Required for Nuclear Reprogramming by Inhibiting Transforming Growth Factor β Signaling Pathway.

Authors:  Qing-Ran Kong; Bing-Teng Xie; Heng Zhang; Jing-Yu Li; Tian-Qing Huang; Ren-Yue Wei; Zhong-Hua Liu
Journal:  J Biol Chem       Date:  2016-11-07       Impact factor: 5.157

4.  Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.

Authors:  Michelle R Jones; Pei-Chen Peng; Simon G Coetzee; Jonathan Tyrer; Alberto Luiz P Reyes; Rosario I Corona; Brian Davis; Stephanie Chen; Felipe Dezem; Ji-Heui Seo; Siddartha Kar; Eileen Dareng; Benjamin P Berman; Matthew L Freedman; Jasmine T Plummer; Kate Lawrenson; Paul Pharoah; Dennis J Hazelett; Simon A Gayther
Journal:  Am J Hum Genet       Date:  2020-09-17       Impact factor: 11.025

Review 5.  Epigenetic regulation in medulloblastoma.

Authors:  Jiaqing Yi; Jiang Wu
Journal:  Mol Cell Neurosci       Date:  2017-12-18       Impact factor: 4.314

6.  REST Final-Exon-Truncating Mutations Cause Hereditary Gingival Fibromatosis.

Authors:  Yavuz Bayram; Janson J White; Nursel Elcioglu; Megan T Cho; Neda Zadeh; Asuman Gedikbasi; Sukru Palanduz; Sukru Ozturk; Kivanc Cefle; Ozgur Kasapcopur; Zeynep Coban Akdemir; Davut Pehlivan; Amber Begtrup; Claudia M B Carvalho; Ingrid Sophie Paine; Ali Mentes; Kivanc Bektas-Kayhan; Ender Karaca; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; James R Lupski
Journal:  Am J Hum Genet       Date:  2017-07-06       Impact factor: 11.025

7.  REST-miR-21-SOX2 axis maintains pluripotency in E14Tg2a.4 embryonic stem cells.

Authors:  Sanjay K Singh; Anantha Marisetty; Pratheesh Sathyan; Mohamedi Kagalwala; Zhaoyang Zhao; Sadhan Majumder
Journal:  Stem Cell Res       Date:  2015-07-02       Impact factor: 2.020

8.  Rest represses maturation within migrating facial branchiomotor neurons.

Authors:  Crystal E Love; Victoria E Prince
Journal:  Dev Biol       Date:  2015-03-11       Impact factor: 3.582

9.  SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.

Authors:  X Shi; Q Wang; J Gu; Z Xuan; J I Wu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

Review 10.  The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities.

Authors:  David Mu
Journal:  J Biol Chem       Date:  2013-07-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.